Live Breaking News & Updates on Lifesci Venture Partners

Stay updated with breaking news from Lifesci venture partners. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Orasis Pharmaceuticals to Present New Data on Novel Presbyopia Candidate at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

/PRNewswire/ Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing a unique eye drop to improve near vision for people. ....

United States , Tel Aviv , Amy Phillips , Marjan Farid , Preeyak Gupta , Elad Kedar , American Society For Cataract , Japan Innovation Fund , Sequoia Capital , Orasis Pharmaceuticals , Prnewswire Orasis Pharmaceuticals , Refractive Surgery , Annual Meeting , Chief Executive Officer , Orasis Pharmaceutical , New Treatments , Visionary Ventures , Innovation Fund , Bluestem Capital , Lifesci Venture Partners , Maverick Ventures Israel , Health Care Amp Hospitals , Biotechnology , Medical Pharmaceuticals , Pharmaceuticals , Trade Show News ,

Orasis Pharmaceuticals Appoints Teresa (Tes) Ignacio, M.D. as Vice President, Medical Affairs

HERZLIYA, Israel, April 7, 2022 /PRNewswire/ Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing a uniq. ....

Tel Aviv , Amy Phillips , Paul Smith , Refractive Research , Makati Medical Center , Japan Innovation Fund , Orasis Pharmaceuticals , Prnewswire Orasis Pharmaceuticals , Prnewsfoto Orasis Pharmaceuticals , Sequoia Capital , Vice President , Chief Operating Officer , Refractive Research Fellow , About Orasis , Visionary Ventures , Innovation Fund , Bluestem Capital , Lifesci Venture Partners , Maverick Ventures Israel ,

Orasis Pharmaceuticals Concludes Phase 3 Clinical Trials for Presbyopia Candidate

Study enrollment complete for NEAR-1 and NEAR-2 Phase 3 Clinical TrialsHERZLIYA, Israel, March 15, 2022 /PRNewswire/ Orasis Pharmaceuticals, an. ....

Tel Aviv , Amy Phillips , Elad Kedar , Japan Innovation Fund , Sequoia Capital , Orasis Pharmaceuticals , Prnewswire Orasis Pharmaceuticals , Chief Executive Officer , Visionary Ventures , Innovation Fund , Bluestem Capital , Lifesci Venture Partners , Maverick Ventures Israel ,

Orasis Pharmaceuticals Concludes Phase 3 Clinical Trials for Presbyopia Candidate

Press release content from PR Newswire. The AP news staff was not involved in its creation. ....

Tel Aviv , Amy Phillips , Elad Kedar , Japan Innovation Fund , Sequoia Capital , Orasis Pharmaceuticals , Prnewswire Orasis Pharmaceuticals , Chief Executive Officer , Visionary Ventures , Innovation Fund , Bluestem Capital , Lifesci Venture Partners , Maverick Ventures Israel , Pr Newswire , Clinical Trials ,

Clade Therapeutics Announces the Appointment of Derek Hei, Ph.D., as Chief Technology Officer

Press release content from Globe Newswire. The AP news staff was not involved in its creation. ....

United States , United Kingdom , Ligia Vela Reid , Waisman Biomanufacturing , Bristol Myers Squibb , University Of Wisconsin , Regulatory At Cellular Dynamics International , University Of California , Gene Therapies At Vertex Pharmaceuticals , Derek Hei , Chief Technology Officer , Chad Cowan , Chief Executive Officer , Senior Vice President , Clinical Manufacturing , Gene Therapies , Vertex Pharmaceuticals , Bluerock Therapeutics , Clinical Manufacture , Cellular Dynamics International , Lifesci Venture Partners , Emerson Collective , Globe Newswire ,